Current trends in Ophthalmology
Date: 12/06/2019
Venue: 186 EXHIBITION ST MELBOURNE, VIC, 3000
Provider: Sunbury Eye Surgeons
Contact: Vivan Nguyen, [E] reception@sunburyeyesurgeons.com.au, [P] 03 9740 9555
Learning Objectives
- To appreciate the specific subtypes of drusen that increase the risk of AMD and to know how to look for these clinically
- To understand the AREDS study and how it relates to clinical practice and in giving advice to patients
- To appreciate the use of OCT as a modality to differentiate drusen subtypes
- To understand the EAGLE study and its findings and correlate this to clinical practice
- To appreciate the role of laser peripheral iridotomy (PI) in preventing angle closure: understanding the evidence.
- To become familiar with other treatment procedures including iridoplasty.
- To develop a clear differential diagnosis list for a chronic lid lesion based on clinical and demographic characteristics alone
- To appreciate simple chronic lid margin disease and its role in contributing to malignancy
- To understand the etiological principles involved in entropian and ectropian formation
Max points awarded: 4.50
Session Information
Name |
---|
Exudative AMD: Who is most at risk? |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.50 |
Name |
---|
Angle Closure |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.50 |
Name |
---|
Lumps and Bumps |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.50 |
Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
---|---|---|---|---|
Exudative AMD: Who is most at risk? | Face to Face with Assessment | No | No | 1.50 |
Angle Closure | Face to Face with Assessment | No | No | 1.50 |
Lumps and Bumps | Face to Face with Assessment | No | No | 1.50 |